News
Results from the Phase III EPCORE FL-1 trial (NCT05409066) showed that patients treated with Epkinly (epcoritamab) in combination with Rituxan (rituximab) and Revlimid (lenalidomide) for relapsed or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback